Most peptide therapy is not covered by insurance. The handful of peptides that are covered fall under specific FDA-approved medications for diagnosed conditions like diabetes, growth hormone deficiency, or obesity. The broader category of peptide therapy marketed by wellness clinics, including popular peptides like BPC-157, CJC-1295, and ipamorelin, is almost always an out-of-pocket expense.
Why Most Peptide Therapy Falls Outside Coverage
Insurance companies cover treatments that have FDA approval for a specific medical condition. Many of the peptides offered at anti-aging and wellness clinics are either compounded (custom-mixed by specialty pharmacies) or used off-label for purposes the FDA hasn’t approved. That puts them in a gray zone where insurers have no obligation to pay, and almost none do.
The peptides you’ll find at these clinics, often promoted for muscle recovery, fat loss, gut healing, or general vitality, don’t have the large-scale clinical trials behind them that FDA approval requires. Without that approval, there’s no billing code that would trigger reimbursement from your insurer. This is the core reason the answer is usually no.
Peptides That Insurance Does Cover
Several FDA-approved medications are technically peptides or peptide-based, and these do get insurance coverage when prescribed for their approved uses. The most prominent examples right now are GLP-1 receptor agonists used for type 2 diabetes and, increasingly, for obesity. Insulin is itself a peptide hormone, and newer formulations continue to receive approval. Growth hormone therapy for diagnosed deficiency is another category where peptide-based treatments are routinely covered.
The key distinction is that these are FDA-approved drugs prescribed for specific diagnoses. Your doctor isn’t calling it “peptide therapy.” They’re prescribing a named medication for a documented condition, and the insurance claim reflects that diagnosis.
GLP-1 Coverage for Weight Loss
GLP-1 medications for weight management are the most common place where “peptide therapy” and insurance coverage overlap, though coverage varies dramatically. Many private insurers now cover GLP-1s for obesity when you meet certain criteria, but Medicaid coverage for obesity treatment remains optional at the state level. When coverage exists, it typically comes with prior authorization requirements that can slow or block access.
To get prior authorization approved, your doctor generally needs to document your BMI and weight history, show that you’ve already tried lifestyle changes like diet and exercise, list any obesity-related health conditions you have, and explain why other treatments haven’t worked. This paperwork process can take weeks, and denials are common enough that many patients end up paying out of pocket or appealing the decision.
Growth Hormone Peptides and Insurance
FDA-approved growth hormone therapy is covered by most insurers, but only for confirmed growth hormone deficiency with strict diagnostic proof. The bar is high. For adults, insurers typically require documented failure of at least two growth hormone stimulation tests, with hormone levels falling below specific thresholds. If you have broader pituitary dysfunction affecting multiple hormones, the requirements may be slightly different, but you still need extensive lab work and specialist documentation.
Once approved, you’ll need periodic follow-up labs to confirm the dose is appropriate and that treatment is still warranted. Insurers review these cases on renewal, so coverage isn’t guaranteed indefinitely.
This is very different from what wellness clinics offer. Clinics frequently prescribe growth hormone-releasing peptides like CJC-1295, ipamorelin, or sermorelin to people who don’t meet the clinical definition of growth hormone deficiency. These peptides stimulate your body to produce more growth hormone rather than replacing it directly. They lack FDA approval for this use, and insurance won’t cover them.
What You’ll Pay Out of Pocket
If you’re pursuing peptide therapy through a clinic, expect to pay between $150 and $500 per month depending on which peptide you’re using, your dose, and how long you stay on treatment. Growth hormone-releasing peptides like CJC-1295 and ipamorelin tend to land on the higher end of that range because of their specialized compounding process. Simpler peptides may cost less, but the price adds up over treatment courses that often last several months.
These costs typically include the peptide itself and may or may not include consultation fees, lab work, and follow-up appointments. Some clinics bundle everything into a monthly membership, while others charge separately for each component. Ask for a full cost breakdown before starting treatment.
Using HSA or FSA Funds
Health savings accounts and flexible spending accounts offer a partial workaround. Many peptide therapy clinics accept HSA and FSA payments, which at least lets you use pre-tax dollars. However, for an expense to qualify as HSA or FSA eligible, it technically needs to be for the diagnosis, treatment, or prevention of a medical condition. Purely cosmetic or wellness-oriented uses may not qualify under IRS rules, even if a clinic accepts the payment method.
If you plan to use HSA or FSA funds, having a documented medical reason for the therapy and a prescription from a licensed provider strengthens your position. Keep receipts and any letters of medical necessity in case your account administrator or the IRS questions the expense.
How to Check Your Specific Coverage
If your doctor is recommending a specific FDA-approved peptide medication for a diagnosed condition, call the member services number on your insurance card and ask whether that exact drug is on your plan’s formulary. Ask about prior authorization requirements and any step therapy rules, which require you to try cheaper alternatives first.
If you’re considering clinic-based peptide therapy for wellness, anti-aging, or performance goals, the realistic expectation is that you’ll be paying entirely out of pocket. No amount of prior authorization paperwork will change the fact that these treatments lack the FDA approval insurers require. Budget accordingly, and factor in the full duration of treatment rather than just the first month’s cost.